News | October 21, 2007

SAVI Breast Brachytherapy Reaches 100-Patient Milestone

October 22, 2007 - Cianna Medical recently announced that 100 patients have been treated with the SAVI applicator, a single-entry, multi-catheter applicator that delivers radiation therapy as part of breast conservation therapy.

By using a more precisely targeted dose of radiation, SAVI treats the tissue surrounding the lumpectomy cavity while minimizing radiation dose to healthy tissue. Instead of the six week course of treatment required by whole breast radiation, treatment with the SAVI applicator lasts just five days. This approach is becoming a more widely used alternative to whole breast irradiation, according to the manufacturer.

“SAVI is becoming a very important tool in the management of our breast cancer patients, because we can deliver breast brachytherapy to more patients than we could with its predecessor,” said Constantine Mantz, M.D., radiation oncologist with 21st Century Oncology.

“The great advantage of partial breast irradiation is that it expedites the course of radiation therapy that a woman would receive following surgery,” said Dr. Mantz. “Because SAVI is a multi-catheter device we can exert far greater control over how radiation is delivered in the breast. We have the luxury of being able to place the device very close to the skin or very close to the chest wall and still deliver a safe and effective treatment.”

Radiation treatment after a lumpectomy has traditionally involved irradiation of the entire breast with an external beam. This “whole breast irradiation” exposes more healthy tissue and involves a lengthy treatment course, with radiation delivered five times a week over a six-to-seven week period.

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...